Moleculin Biotech
MBRX • NASDAQ
Moleculin Biotech is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Walter V. Klemp, with a market cap of $13.0M.
CEOWalter V. Klemp
Next Earnings
Upcoming earnings announcement for Moleculin Biotech
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.64
Earnings History
Past 12 earnings reports for Moleculin Biotech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$26.06Est: -$6.77 | -284.9% | - | — | — |
| Nov 13, 2025 | Q3 2025 | -$0.68Est: -$0.22 | -209.1% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.49Est: -$0.16 | -206.2% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.69Est: -$0.71 | +2.8% | - | — | 10-Q |
| Mar 21, 2025 | Q4 2024 | -$0.37Est: -$1.33 | +72.2% | - | — | 10-K/A |
| Nov 8, 2024 | Q3 2024 | -$2.85Est: -$2.44 | -16.8% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1.70Est: -$2.31 | +26.4% | - | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$2.02Est: -$3.53 | +42.8% | - | — | 10-Q |
| Mar 22, 2024 | Q4 2023 | -$5.09Est: -$3.05 | -66.9% | - | — | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$2.85Est: -$3.60 | +20.8% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$3.00Est: -$4.05 | +25.9% | - | — | — |
| May 11, 2023 | Q1 2023 | -$4.20Est: -$3.75 | -12.0% | - | — | — |